Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 1Cancer Pain 1

Interventions

Morphine 2resiniferatoxin 1incobotulinumtoxinA 1fulranumab 1cannabichromene 1alvimopan 1Tablets 1Surveys and Questionnaires 1Standard of Care 1Pain Management 1Oxycodone 1Occupational Therapy 1Massage 1Lidocaine 1Lenalidomide 1Ketamine 1Gels 1Fentanyl 1Dronabinol 1Cannabidiol 1Animal Assisted Therapy 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Cancer Pain × fulranumab × Clear all
NCT00929188 2016-01-22

A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain

Janssen Research & Development, LLC

Phase 2 Completed
100 enrolled

Cancer Pain, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡